Larvol Delta - Opicapone-Shows-No-Superiority-Over-Placebo-for-FluctuationRelated-Pain-in-Phase-4-Parkinson-Trial

Ongentys (opicapone) - Ono Pharmaceutical, Neurocrine Biosciences, BIAL

https://www.neurologylive.com/view/opicapone-shows-no-superiority-over-placebo-fluctuation-related-pain-phase-4-parkinson-trial

Sep 16, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Next